Vol 15, No 6 (2019)
Congress abstract / Abstract
Published online: 2020-01-10

open access

Page views 392
Article views/downloads 465
Get Citation

Connect on Social Media

Connect on Social Media

EOTTD Meeting in Berlin, July 5–6, 2019

Magdalena Miedzińska1
Oncol Clin Pract 2019;15(6):339-341.

Abstract

On the begining of July 2019 took place international EOTTD conference (The European Organization for the Treatment of Trophoblastic Disease). The meeting place was in the one of the largest university hospitasl in Europe, the Charité hospital in Berlin. The main postulate of this year's EOTTD conference was to emphasize the role of instant and correct clinical, biochemical, pathomorphological, immunohistochemical and genetic diagnosis, conducting intensive, compliant with treatment recommendations and the need to assess the quality of life of patients. National registers, the creation of reference centers and their cooperation should serve to achieve these goals.

Article available in PDF format

View PDF Download PDF file

References

  1. Bolze PA, Attia J, Massardier J, et al. EOTTD group. Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases. Eur J Cancer. 2015; 51(13): 1725–1731.
  2. FIGO Oncology Committee report: FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynecol Obstet. 2002; 77(3): 285–287.
  3. Frijstein MM, Lok CAR, Short D, et al. The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia. Eur J Cancer. 2019; 109: 162–171.
  4. Bolze PA, Patrier S, Massardier J, et al. PD-L1 expression in premalignant and malignant trophoblasts from gestational trophoblastic diseases is ubiquitous and independent of clinical outcomes. Int J Gynecol Cancer. 2017; 27(3): 554–561.
  5. Ghorani E, Kaur B, Fisher RA, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 2017; 390(10110): 2343–2345.
  6. Frijstein MM, Lok CAR, van Trommel NE, et al. Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database. Gynecol Oncol. 2019; 152(2): 361–367.
  7. Gadducci A, Carinelli S, Guerrieri ME, et al. Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy. Gynecol Oncol. 2019; 153(3): 684–693.